Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of... ( NEW BRUNSWICK N.J. June 9 /- Senesco...)

HOME >> BIOLOGY >> TECHNOLOGY

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

Date:6/9/2009

NEW BRUNSWICK, N.J., June 9 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (NYSE Amex: SNT) today announced the appointment, effective June 8, 2009, of its current Board member, Dr. Harlan Waksal, M.D., to serve as Chairman of the Board, succeeding Mr. Rudolf Stalder, who has been the Company's Chairman since January 2000. Mr. Stalder will continue serving on the Board and also serve as a member of a newly formed Executive Committee that includes Dr. Harlan Waksal, Mr. Christopher Forbes and Mr. Rudolf Stalder.

Dr. Waksal joined the Board of Senesco in October 2008. Dr. Waksal is President and sole Proprietor of Waksal Consulting L.L.C. in Montclair, NJ. From 1984 through July 2003, he was with ImClone Systems Inc., New York, NY, serving most recently as President, Chief Executive Officer and Chief Operating Officer.

Dr. Waksal is a member of the Board of Trustees of Oberlin College Ohio, a member of the Board of Trustees and chair of the New Jersey Region of the American Committee for the Weizmann Institute of Science in New York, and a member of the Board of Trustees of the Montclair Art Museum.

The Board is also pleased to announce, effective June 8, 2009, the appointment of Mr. Warren J. Isabelle, CFA to the Board. Mr. Isabelle is a founder and principal of Ironwood Investment Management L.L.C., located in Boston, MA. From 1983-1997, Mr. Isabelle was with Pioneer Management Corporation where he served most recently as Director of Research and Head of U.S. Equities. Mr. Isabelle also serves as a member of the Public Board and the Investment Committee of the University of Massachusetts Foundation.

Mr. Stalder commented, "With Senesco's groundbreaking technologies, its research focus on human health and its plans to move diligent
'/>"/>

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
2. Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
3. Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
4. Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
5. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
6. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
7. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
8. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
9. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
10. Senesco Technologies to Present at BIO 2008 Business Forum
11. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results

Post Your Comments:

Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of...( NEW BRUNSWICK N.J. June 9 /- Senesco...)